Biocept Reports 2016 Third Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Feltl & Co Upgrades Biocept (BIOC) to Buy
November 10, 2016 12:55 PM ESTFeltl & Co upgraded Biocept (NASDAQ: BIOC) from Hold to Buy with a price target of $1.55.
For an analyst ratings summary and ratings history on Biocept click here. For more ratings news on Biocept click here.
Shares of Biocept closed at $0.55 yesterday.
... MoreBiocept (BIOC) Reports Q3 Loss of $0.57/Share
November 9, 2016 4:36 PM ESTBiocept (NASDAQ: BIOC) reported Q3 EPS of ($0.57), versus ($0.72) reported last year. Revenue for the quarter came in at $1.05 million, versus $165 thousand reported last year.
For earnings history and earnings-related data on Biocept (BIOC) click here.
... More